|
Office of Science and Technology Mo99 Stakeholders Working Group
|
Committee, Work group, Advisory group, or Task Force
|
CMS, FDA, OSG
|
NIBIB, NCI
|
The purpose of this working group is to coordinate the efforts of multiple stakeholders (Department of State, Department of Energy, Department of Homeland Security, Department of Health and Human Services, private sector) to establish a stable, long-term domestic supply of Mo99 (molybdenum-99) for medical purposes. Such a supply needs to be consistent with current international goals (to which the US is an active participant) of reduction in the use of high-enriched uranium in all reactors, including Mo99 production facilities, as well as full cost recovery solutions. The National Institutes of Health (NIH) staff attended a stakeholders workshop was held in the Spring of 2018, see https://mstakeholders/o99.ne.anl.gov/
|
|
Oral Health & Aging: Information for Caregivers
|
Public Education Campaign
|
ACL, HRSA, OS
|
NIDCR, NIA
|
Fact sheets designed to provide caregivers with information they need to assist older adults with oral hygiene. There are four fact sheets in the series: Brushing, Flossing, Dry Mouth, and Finding Low-Cost Dental Care.
|
|
OSTP Interagency Working Group on Medical Imaging
|
Committee, Work group, Advisory group, or Task Force
|
CMS, FDA
|
NIBIB, NCI, NIAMS, NICHD, NIDDK
|
The Interagency Working Group on Medical Imaging (IWMI) is co-chaired by the National Institutes of Health (NIH) and the National Institute of Standards and Technology (NIST) and is working to identify gaps and develop a roadmap to accelerate technology development that is more effective, improves patient care, and has the potential to lower cost. The working group, which includes twelve federal agencies, has determined key strategic directions through a series of stakeholder meetings. Areas identified as important for joint focus include deep/machine learning, quantitative and high-value imaging, and inter-agency collaboration to accelerate translation. The working group released its final report on December 22, 2017. The charter for this working group was not renewed in 2018.
|
|
P63, P13K and RAS oncogenes in tumorigenesis, immune deregulation and therapy of squamous cell carcinoma
|
Research Initiative
|
FDA
|
NIDCD
|
At the Food and Drug Administration (FDA), Dr. Weinberg is transducing murine keratinocytes with combinations of oncogenes found in human squamous cell carcinomas to determine if they generate transformation and tumors in laboratory conditions. Dr. Van Waes’ laboratory at the National Institute on Deafness and Other Communication Disorders (NIDCD) will study how these oncogene-driven tumors in mice deregulate keratinocytes and host immune responses, as well as response to various standard, molecular, and immune therapies.
|
|
Partners in Information Access for the Public Health Workforce
|
Resource Development
|
AHRQ, CDC, HRSA, OS
|
NLM
|
Partners in Information Access for the Public Health Workforce is a collaboration of US government agencies, public health organizations, and health sciences libraries that provides timely, convenient access to selected public health resources on the Internet.
|
|
Pathogen Detection Project and Interagency Collaboration on Genomics for Food and Feed Safety (Gen-FS)
|
Resource Development
|
CDC, FDA
|
NLM
|
The Pathogen Detection Project is a multi-agency collaboration that is combining data from pathogen outbreaks with other information to determine the major source of contamination. The project is conducted via a centralized system that integrates sequence data for bacterial pathogens obtained from food, the environment, and human patients. A number of public health agencies in the US and internationally are collecting samples from these sources to facilitate active, real-time surveillance of pathogens and foodborne disease. The agencies sequence the samples and submit the data to the National Center for Biotechnology Information (NCBI), a division of the National Library of Medicine (NLM) at the National Institutes of Health (NIH), which analyzes the sequences against others in its database to identify closely related sequences. The aim is to uncover potential sources of contamination by linking isolates from food or the environment to human illness and to quickly report the sequence relationships to public health scientists in order to aid traceback investigations and outbreak response. Collaborating agencies include the Food and Drug Administration (FDA), the Centers for Disease Control and Prevention (CDC), USDA-Food Safety and Inspection Service, and Public Health England. The US agencies formalized their collaboration in a charter document (Interagency Collaboration on Genomics for Food and Feed Safety (Gen-FS)) that includes coordinating activities on antimicrobial resistance.
|
|
Pathways to Prevention (P2P) Workshop Program
|
Meeting/ Workshop
|
AHRQ
|
OD/DPCPSI/ODP
|
The Pathways to Prevention (P2P) program is a workshop series hosted by the Office of Disease Prevention (ODP) to identify research gaps in a selected scientific area, identify methodological and scientific weaknesses in that scientific area, suggest research needs, and move the field forward through an unbiased, evidence-based assessment of a complex public health issue. P2P workshops are designed for topics that have incomplete or underdeveloped research and for which there is a need for a systematic evidence review that synthesizes the published literature. After each workshop, ODP also organizes a meeting of all Federal Partners who have an interest in or activities related to the workshop topic to discuss ways that the Federal Partners might collaborate to implement workshop recommendations.
|
|
Patient-Centered Outcomes Research Clinical Decision Support Learning Network (PCOR CDS-LN) Advisory Council
|
Committee, Work group, Advisory group, or Task Force
|
AHRQ, OS
|
NLM
|
This council provides a forum for stakeholders to assess both barriers and facilitators to implementing PCOR findings in CDS and make recommendations for optimizing PCOR-enabled CDS to facilitate improvements in care and outcomes. The PCOR CDS-LN is funded through a cooperative agreement with the Agency for Healthcare Research and Quality
|
|
Pediatric Device Consortia Grants Program
|
Research Initiative
|
FDA
|
NICHD
|
The goal of the Food and Drug Administration (FDA) Pediatric Device Consortia (PDC) Grants Program is to facilitate the development, production, and distribution of pediatric medical devices through funding of nonprofit consortia.
|
|
Physical Activity and Healthcare Utilization and Costs in Older Adults
|
Research Initiative
|
CDC
|
NCI
|
Through this initiative, the Centers for Disease Control and Prevention (CDC) and the National Cancer Institute (NCI) plan to investigate the association between physical activity over the life-course on later life health care utilization and costs in Medicare recipients in the AARP Cohort.
|